Human medicines European public assessment report (EPAR): Toujeo (previously Optisulin), insulin glargine, Date of authorisation: 26/06/2000, Revision: 36, Status: Authorised

Human medicines European public assessment report (EPAR): Toujeo (previously Optisulin), insulin glargine, Date of authorisation: 26/06/2000, Revision: 36, Status: Authorised

Human medicines European public assessment report (EPAR): Saphnelo, anifrolumab, Date of authorisation: 14/02/2022, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Saphnelo, anifrolumab, Date of authorisation: 14/02/2022, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Azacitidine Kabi, azacitidine, Date of authorisation: 05/01/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Azacitidine Kabi, azacitidine, Date of authorisation: 05/01/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Tevagrastim, filgrastim, Date of authorisation: 15/09/2008, Revision: 19, Status: Authorised

Human medicines European public assessment report (EPAR): Tevagrastim, filgrastim, Date of authorisation: 15/09/2008, Revision: 19, Status: Authorised

Human medicines European public assessment report (EPAR): Ratiograstim, filgrastim, Date of authorisation: 15/09/2008, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR): Ratiograstim, filgrastim, Date of authorisation: 15/09/2008, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR): Revatio, sildenafil, Date of authorisation: 28/10/2005, Revision: 53, Status: Authorised

Human medicines European public assessment report (EPAR): Revatio, sildenafil, Date of authorisation: 28/10/2005, Revision: 53, Status: Authorised

Human medicines European public assessment report (EPAR): Iasibon, ibandronic acid, Date of authorisation: 21/01/2011, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): Iasibon, ibandronic acid, Date of authorisation: 21/01/2011, Revision: 13, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.